Page 12 - EFSD Programme Portfolio_2018
P. 12

Type 1 Diabetes Research

                   EFSD/JDRF/Lilly European Programme in
                          Type 1 Diabetes Research 2018

  Who:

InveHsotwigamtourcsh?from single non-profit institutions or groups of such institutions from

EurWopWheahatan?td? associated countries.

  What or Programme Focus:

ThisHoPwromgurcahm?me offers grants for high quality basic biomedical and clinical

reseWaWhrcahhta?ta?pplicable to type 1 diabetes.

Several areas of particular interest are specified in the RFA and may be modified with
each year’s call; please read the relevant RFA for further guidance. For information
only, the 2018 Call included but was not limited to research with potential to increase
understanding of the natural history, pathogenesis, heterogeneity and/or aetiology of
human type 1 diabetes; pancreatic beta cell biology with a focus on discovery and
validation of potential therapeutic targets and approaches to promote the survival,
expansion and/or regeneration of human beta cells; pathophysiology of type 1 diabetes
autoimmunity with a focus on potential therapeutic targets and testing of autoantigen-
specific immunoregulation of type 1 diabetes; development and/or testing of therapies
that slow or stop the progression of type 1 diabetes before symptomatic disease or that
preserve beta cell function in new onset type 1 diabetes; biomaterials and novel
concepts for implantable, encapsulated beta cell replacement; automated closed loop
artificial pancreas systems and/or its components; novel or repurposed therapies to
improve glycaemic and overall metabolic control in type 1 diabetes; novel insulins;
therapies that prevent progression of diabetic kidney or eye disease in type 1 diabetes;
beta cell targeting for drug delivery and imaging; diagnostic, prognostic or predictive
biomarkers for all stages of type 1 diabetes to enable “smart” clinical trials.

  When:

201H8odwemadulcinhe?: 1 July 2018

  HoWwWhamhtau?tc?h:
GraWntshaatr?e up to Euro 100,000 for basic research projects

        and up to Euro 400,000 for clinical research projects*.
         *The definition of clinical research is a study performed in vivo, in human individuals
        with focus on clinically relevant and diabetes-related outcomes.

                                                                                                                                      11
   7   8   9   10   11   12   13   14   15   16   17